Publications

Showing 1–7 of 7 results from Publika

Louch WE, Perdreau-Dahl H, Edwards AG (2022)
Image-Driven Modeling of Nanoscopic Cardiac Function: Where Have We Come From, and Where Are We Going?
Front Physiol, 13, 834211
PubMed 35356084 DOI 10.3389/fphys.2022.834211
Setterberg IE, Le C, Frisk M, Perdreau-Dahl H, Li J, Louch WE (2021)
Corrigendum: The Physiology and Pathophysiology of T-Tubules in the Heart
Front Physiol, 12, 790227
PubMed 34764889 DOI 10.3389/fphys.2021.790227
Perdreau-Dahl H, Progida C, Barfeld SJ, Guldsten H, Thiede B, Arntzen M, Bakke O, Mills IG, Krauss S, Morth JP (2020)
Sjögren syndrome/scleroderma autoantigen 1 is a direct Tankyrase binding partner in cancer cells
Commun Biol, 3 (1), 123
PubMed 32170109 DOI 10.1038/s42003-020-0851-2
Borg Distefano M, Hofstad Haugen L, Wang Y, Perdreau-Dahl H, Kjos I, Jia D, Morth JP, Neefjes J, Bakke O, Progida C (2018)
TBC1D5 controls the GTPase cycle of Rab7b
J Cell Sci, 131 (17)
PubMed 30111580 DOI 10.1242/jcs.216630
Subramani S, Perdreau-Dahl H, Morth JP (2016)
The magnesium transporter A is activated by cardiolipin and is highly sensitive to free magnesium in vitro
Elife, 5
PubMed 26780187 DOI 10.7554/eLife.11407
Bjerregaard-Andersen K, Perdreau-Dahl H, Guldsten H, Praetorius J, Jensen JK, Morth JP (2013)
The N-terminal cytoplasmic region of NCBE displays features of an intrinsic disordered structure and represents a novel target for specific drug screening
Front Physiol, 4, 320
PubMed 24223558 DOI 10.3389/fphys.2013.00320
Voronkov A, Holsworth DD, Waaler J, Wilson SR, Ekblad B, Perdreau-Dahl H, Dinh H, Drewes G, Hopf C, Morth JP, Krauss S (2013)
Structural basis and SAR for G007-LK, a lead stage 1,2,4-triazole based specific tankyrase 1/2 inhibitor
J Med Chem, 56 (7), 3012-23
PubMed 23473363 DOI 10.1021/jm4000566
1